ARCHIVES

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

This article is from The Cancer Letter archive.

Vol. 26 No. 19 | May 12, 2000

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

September 28, 2001

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

February 25, 2011

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

April 1, 2005

In brief: ring appointed Associate Dean At UCSF; Univ. of Utah Forms Cell Signaling Center

August 1, 1997

NCI 1980s Challenge: Matching Schientific Priorities With Resources, DeVita Says At Swearing-In

August 15, 1980

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

January 10, 2003